Business Context and Reporting Period
This Form 8-K was filed by Reactive Medical Inc. (formerly Knight Knox Development Corp.) on February 10, 2017. The report details the effective date of a corporate name change and an increase in authorized capital approved by stockholders and the board on January 19, 2017.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance changes rather than financial performance.
Material Changes
- Name Change: The company's name changed from Knight Knox Development Corp. to Reactive Medical Inc., effective February 10, 2017.
- Capital Structure: Authorized common stock increased from 75,000,000 to 150,000,000 shares (par value $0.001). Authorized preferred stock was established at 50,000,000 shares (par value $0.001).
- Trading Symbol: The ticker symbol changed to "RMED" on the Over-the-Counter Bulletin Board, effective February 10, 2017.
- Identification: The new CUSIP number is 75524H101.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for future guidance, management outlook, specific risks, or contingencies. The document confirms that the name change was reviewed and approved by the Financial Industry Regulatory Authority (FINRA).
Investor Verification Checklist
- Confirm the new ticker symbol "RMED" is active on the Over-the-Counter Bulletin Board.
- Verify the new CUSIP number 75524H101 in trading systems.
- Review the Certificate of Amendment filed with the Nevada Secretary of State on February 2, 2017.
- Check for subsequent filings regarding the company's operational strategy under the new name.